US Federal Circuit Will Not Stand In Way Of Gilenya Generics

Novartis: ‘Over Twenty ANDA Products Could Enter The US Market’

Gavel
ANDA launches could be imminent • Source: Shutterstock: Chris Bain
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products